english.prescrire.org > Spotlight > 100 most recent > In the February issue of Prescrire International: Idebenone (Raxone°) and Leber hereditary optic neuropathy

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

In the February issue of Prescrire International: Idebenone (Raxone°) and Leber hereditary optic neuropathy

FREE DOWNLOAD In this month's sample page: regulatory agencies are sometimes satisfied with data that do not come from true comparative trials. The case of idebenone in Leber hereditary optic neuropathy is particularly shocking.
Full text available for free download.

Summary

  • Leber hereditary optic neuropathy is a serious disease with no effective treatment in 2016.
     
  • This is no reason to expose patients to the potentially severe adverse effects of idebenone.
     
  • Regulators' failings: the case of idebenone in Leber hereditary optic neuropathy is particularly shocking.

Full text available for free download.

 ©Prescrire 1 February 2017

"Idebenone (Raxone°) and Leber hereditary optic neuropathy" Prescrire Int 2017; 26 (179): 41. (Pdf, free)
Download the full review
Pdf, free